ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ)

CNY 9.27

(1.64%)

Market Cap (In CNY)

2.3 Billion

Revenue (In CNY)

799.3 Million

Net Income (In CNY)

25.19 Million

Avg. Volume

8.39 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.98-11.86
PE
-
EPS
-
Beta Value
0.251
ISIN
CNE1000016D0
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Qun Zhao
Employee Count
-
Website
https://www.cy-pharm.com
Ipo Date
2011-08-19
Details
ShanXi C&Y Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China, the United States, Hong Kong, and internationally. It offers products for pregnant women and babies; urinary system products; anti-infection products; traditional Chinese medicines; and dermatology products, as well as tea bags. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to Shanxi C&Y Pharmaceutical Group Co., Ltd. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is headquartered in Shanghai, China.